Talk to Alison
00 1 718 618 48 97
Search inside this page
Top countries
Publication dates
Publishers
All regions
Free Market Research Guides to Download
» Purchase Premium Reports
1471-1500 of about 2 200 reports
Introduction This analysis examines the historical and projection performance for Genzyme in the prescription pharmaceutical segment . The profile encompasses global industry player strategy, portfolio ...
Biomarkers feature in thousands of published articles each year, evidencing the high level of interest and research in this field. This report focuses on issues that must be addressed to utilize this growing ...
About this report Protein is breaking out of the gym, shaking off its ?body-builder? image and moving onto the radar screen of the ?normal? consumer. Weight management is the strongest and most-used health ...
The white biotechnology market research service analyzes the food and feed industry, pharmaceutical industry, biofuel industry, bioplastics industry, and personal care industry. The current scenario in ...
Orthopedic biomaterial products, which can be organic or synthetic in nature, are implanted into or near a bone fracture to facilitate healing or to compensate for a lack or loss of bone tissue. Biomaterials ...
REPORT DESCRIPTION GLOBAL MARKET WATCH Global stem cells market is forecasts to reach US$63.8 billion by 2015 from an estimated value of US$21.5 billion in 2010, exhibiting a triple fold growth rate during ...
REPORT DESCRIPTION Global Market Watch With a CAGR of 23.7%, global market value for cryopreservation equipments used in stem cells industry is anticipated to worth US$2.2 billion by 2015. On a global ...
The European orthopedic biomaterials markets are expected to approach ?1 billion by 2017, with hyaluronic acid viscosupplementation as the largest segment. The European orthopedic biomaterials markets ...
The European orthopedic biomaterials markets are expected to approach ?1 billion by 2017, with hyaluronic acid viscosupplementation as the largest segment. The European orthopedic biomaterials markets ...
The future of the pharmaceutical market will be determined by biologics - drugs produced by natural organisms or recombinant techniques consisting of proteins and other products derived from living organisms ...
This report provides data on the therapeutic development for Lysosomal Storage Disorder, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key ...
This report provides data on the therapeutic development for Plasma Cell Neoplasm, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...
The report includes data on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from ...
This report provides data on the therapeutic development for Indolent Lymphoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...
Biotech M&A and Licensing Strategies - Co-development Agreements are Poised to Increase in the Future to Counter Drying Pipelines Summary GBI Research's pharmaceutical research, ?Biotech M&A and Licensing ...
This report provides information on the therapeutic development for Primary Systemic Amyloidosis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews ...
Datamonitors' ZymoGenetics, Inc.?s SWOT, Strategy and Corporate Finance Report, is a source of comprehensive industry player data and information. The market research report covers the firm ?s structure, ...
`Opting for the right material to use in a medical device is no longer a complex procedure, barring the fact that such medical devices fabricated using these materials are biocompatible, which can be ensured ...
About This Report The Firms Financials offers insights into the financial performance of the industry player over last five years for about 1000 leading global firms . The datapack covers wealth of financial ...
About This Report The Firms Financials offers insights into the financial performance of the industry player over last five years for about 1000 leading global firms . The datapack covers wealth of financial ...
The report provides industry landscape, competitive landscape and industry trends data on the genetic testing industry . The report provides comprehensive data on the major industry developments affecting ...
Summary The Pharmacogenomic Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the pharmacogenomic partnering deals and agreements entered into by ...
The life science tools market has shown steady growth over the last couple of years despite the economic downturn. This market is currently valued at more than $42 billion and is projected to increase ...
This report analyzes the market for Biotechnology in India in US$ million by the following Key Sectors - Bio-Pharmaceuticals, Bio-Agriculture, Bio-Industrial, Bioinformatics, and Bio-Services. Annual estimates ...
The stem cell market has been growing at a fast pace for the past few years and despite recession, the US continued to witness positive developments and massive investments in this industry. Using stem ...
examines the firm ?s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. ZymoGenetics, a wholly-owned subsidiary of Bristol-Myers ...
An overview of the microbial products market, including a general description of commercial microbes that are bought and sold on the market or used to produce products. Analysis of global market trends, ...
Top 10 Healthcare Trends in 2011 Summary GBI Research has released its latest report, ?Top 10 Healthcare Trends in 2011? that provides key data, information and analysis of the major trends in the biopharmaceutical ...
The report provides key industry ed products, key players and industry dynamics. The report provides comprehensive data on the industry drivers and restraints affecting the industry growth. Scope of the ...
- SWOT Analysis examines the firm ?s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. (CSL) is a biopharmaceutical group ...
» Download Public Reports
About 9 000 reports
... From funding. The doc/nist will review research using human embryonic stem cell lines that it supports and conducts in accordance with the common rule and nist implementing procedures, as appropriate ...
» Read our Company Profiles
99 CompaniesReportlinker.com © Copyright 2013. All rights reserved.